Antithrombotic therapy resumption after intracranial hemorrhage / 中华神经科杂志
Chinese Journal of Neurology
;
(12): 204-211, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-994820
ABSTRACT
Patients with intracranial hemorrhage and indications of antithrombotic therapy are common in clinical practice. However, whether and when to start anticoagulant or antiplatelet therapy after intracranial hemorrhage are still debatable. Clinicians are posed with huge challenges without available guidelines. Through reviewing relevant literature, this article analyzed the risks of thromboembolism and hemorrhage recurrence after initiation of anticoagulant or antiplatelet therapy in patients with intracranial hemorrhage due to various etiologies. This article also presented the initiation time and specific antithrombotic plan in current clinical practice, aiming to propose references for clinicians.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Neurology
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS